市場調查報告書
商品編碼
1054118
流動化學的全球市場與市場預測: 各技術,各應用領域,各終端用戶,各地區(~2028年)Flow Chemistry Market Forecasts to 2028 - Global Analysis By Technology (Photochemistry, Gas Based), Application (Polymers, Chemicals, Surgical), End User (Laboratories, Beverage, Agrochemicals) and By Geography |
全球流動化學的市場規模在2021年估算為7,834萬美元,到2028年前將達到1億8,684萬美元,在2021年到2028年的預測期間內年複合成長率預測將為13.2%。
本報告提供全球流動化學市場相關調查分析,提供市場趨勢分析,市場分析,主要的開發,企業簡介等系統性資訊。
According to Stratistics MRC, the Global Flow Chemistry Market is accounted for $88.70 million in 2022 and is expected to reach $186.84 million by 2028 growing at a CAGR of 13.2% during the forecast period. Flow chemistry is a technology in which a chemical reaction is run in a continuously flowing stream rather than in batch production and this technique has also enabled many chemical processes to be more efficient, safer, faster, cleaner, and cheaper. It is expected to resolve difficulties related to the size of distribution of particles, irreproducibility of size, and the quality of the nanomaterial.
Many of the benefits of flow chemistry come down to the reactors' high surface area to volume ratio, Levesque explains. Temperature changes are much easier to manage, eliminating cryogenic conditions that are hard to implement in large scale industrial reactors. Mixing is also much better. This typically provides better reaction control, which in turn can lead to higher yields and more sustainable processes. In making potential respiratory drug gefapixant, for example, Merck used a flow process to tightly control the reaction, improving its safety and the sustainability. As an example of simplifying a difficult process, Baumann cites a Matteson reaction used by Thermo Fisher Scientific. This involves removing a hydrogen atom from dichloromethane and replacing it with a lithium ion, then reacting it with an electrophile. To make the intermediate at batch scale involves cooling to -100°C. In flow processes the time an intermediate exists for is determined by the flow rate, which meant Thermo Fisher scientists only had to cool to -80°C. 'That allows you to reproducibly generate the lithiated dichloromethane and quench it within half a minute before it can decompose.
Driver:
Increasing demand from pharmaceutical sector
The flow chemistry technology is being extensively employed in the pharmaceutical sector for its role in drug discovery, chemical process development and production of pharmaceutical drugs. Flow chemistry was introduced in the pharmaceutical sector in the early 2000s when researchers began developing systems for Active Pharmaceutical Ingredients (APIs) and intermediate synthesis. For almost a decade, flow chemistry has grown from an innovative synthesis concept to a versatile & powerful platform for the continuous manufacturing of APIs with a small manufacturing footprint, high productivity, and reduced waste & cost.
Restraint:
Requirement of specialised equipment
The disadvantage of flow chemistry is that more specialised equipment is required. The choice and cost of this equipment can make flow chemistry difficult to access. Since flow chemistry is part-engineering and part-chemistry there isn't always the broad skillset required to make the leap to this very powerful technique. For example, if reaction tubing clogs, heterogeneous mixtures may be a little more difficult to process.
Opportunity:
Technological advancements
With rising concerns regarding climate change and the hazardous applications of chemical reactions on the environment, flow chemistry is emerging as an eco-friendly and safe chemical technology. The use of flow reactors has proven to be effective in the large-scale production of biodiesel from waste. This will provide immense business opportunities to the vendors of the market in concern during the forecast period.
The plug flow reactors (PFR) segment is expected to be the largest during the forecast period
Plug flow reactors are highly suitable for rapid reactions and large capacity processes which is expected to increase its utilization in pharmaceutical and chemical manufacturing. These reactors provide huge opportunities for scaling up the production process at a low cost which is anticipated to have a positive impact on market growth in the forthcoming years.
The chemicals segment is expected to have the highest CAGR during the forecast period
Increasing demand for specialty & fine chemicals coupled with a rising focus on scaling up the production processes is expected to propel the demand for flow reactors in the chemical industry. Flow chemistry aids in reducing the number of steps and reaction rate which is likely to have a positive impact on the market growth.
Region with largest share:
Asia Pacific is projected to hold the largest market share owing to the rising health awareness, leading to increasing demand for generic drugs, is expected to propel the utilization of flow chemistry processes to scale up the manufacturing of generic drugs in the region. Furthermore, increasing investment in the chemical and pharmaceutical industry especially in India, China, and Japan is expected to benefit the market over the forecast period. For example, Syrris launched its automatic reagent injector in Asia. The product provides high throughput due to automatic sample injection through two independent channels and can synthesize complex matrix libraries.
Region with highest CAGR:
North America is projected to have the highest CAGR as U.S is the largest market for flow chemistry in North America. High chemical and pharmaceutical manufacturing coupled with increasing investment by the petrochemical manufacturers is expected to play a key role in driving the regional demand in the forthcoming years.
Some of the key players profiled in the Flow Chemistry Market include Biotage AB, Syrris Ltd., Vapourtec Ltd., ThalesNano Inc., Uniqsis Ltd., Chemtrix BV, Cambridge Reactor Design Ltd., PDC Machines Inc., CEM Corporation, Future Chemistry Holding BV, Corning Incorporated and Lonza Group Ltd.
In February 2016: Chemtrix appointed Central Scientific Commerce as its distributor in Japan in order to facilitate direct reactor sales and customer support to the R&D and production communities in the economy.
In November 2015: Biotage AB opened a demonstration & application lab in Sweden which facilitated further research across all the product lines of the company.
Technologies Covered:
Reactors Covered:
Applications Covered:
End Users Covered:
Regions Covered:
All the customers of this report will be entitled to receive one of the following free customization options:
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.